Shenzhen Chipscreen Biosciences Co Price/Sales
What is the Price/Sales of Shenzhen Chipscreen Biosciences Co?
The Price/Sales of Shenzhen Chipscreen Biosciences Co., Ltd. is 15.97
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on SSE compared to Shenzhen Chipscreen Biosciences Co
What does Shenzhen Chipscreen Biosciences Co do?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Companies with price/sales similar to Shenzhen Chipscreen Biosciences Co
- MFS Charter Income Trust has Price/Sales of 15.90
- Blockchain Industries has Price/Sales of 15.91
- Eaton Vance New York Municipal Bond Fund has Price/Sales of 15.91
- Sino AG has Price/Sales of 15.91
- Principal Real Estate Income Fund has Price/Sales of 15.94
- Hibernia REIT Plc has Price/Sales of 15.96
- Shenzhen Chipscreen Biosciences Co has Price/Sales of 15.97
- ProAm Explorations has Price/Sales of 15.97
- Hibernia REIT Plc has Price/Sales of 16.01
- Stampede Capital has Price/Sales of 16.01
- StarPower Semiconductor has Price/Sales of 16.02
- Creative Eye has Price/Sales of 16.05
- 3i Infotech has Price/Sales of 16.07